calcium carbonate

FDA Approved

Description

Calcium supplementation used in bone dysplasias and skeletal disorders to support bone mineralization and density. Provides essential mineral supplementation for patients with brachydactyly and other skeletal abnormalities where bone metabolism may be compromised.

Indications & Therapeutic Use

calcium deficiency, osteoporosis prevention, bone dysplasias, skeletal support

Linked Diseases:

brachydactyly
Q68.1D059327

Global Availability (8 countries)

CountryAccess RouteRegulatory PathwayLead TimeStatus

Available Through

This drug is available for procurement through the following fulfilment partner.

Fulfilment Partner
calcium carbonate
Generic Namecalcium carbonate
Brands1 brand available
Active Ingredientcalcium carbonate
Drug Classcalcium deficiency
ManufacturerPfizer
Dosage Formsoral tablet 500mg, 600mg, 1000mg; chewable tablet 500mg
Medical CodeA12AA04
Orphan StatusNo
Cold ChainNot Required
Lead Time3 days
Reg. StatusFDA Approved
Countries8 countries
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes